Hey friends, welcome to my backyard! I'm going to take you through an hour long yin yoga practice for flexibility and stress relief. This is a really relaxing full body stretch that can be practiced ...

Sun salutations are a wonderful way to build strength and flexibility while also building the mind-body connection. I'll be ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

This 8-step yoga flow is sure to bring you that much-needed relaxation so you can keep handle everything the holidays throws at you.

The antiviral and antibacterial qualities of garlic's allicin aid to soften mucus for easy ejection while combating cold viruses and subsequent bacterial infections. Adults can apply the cure multiple ...

A decongestant is a medication that helps ease nasal congestion, which happens when something irritates the lining of your nose. This can result from a cold, the flu, or allergies, for example.

Leggo. Hatha Yoga Slow-paced with basic poses and breathing techniques. Beginners improving flexibility and posture. Vinyasa Yoga Dynamic, flow-based, syncing poses with breath. Building strength with ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...